Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates

被引：6

作者：

Sun, Huihua ^{[1
]}

Zhang, Hongfang ^{[1
]}

Ee Lui Ang ^{[1
]}

Zhao, Huimin ^{[1
,2
]}

机构：

[1] Agcy Sci Technol & Res, Sci & Engn Inst, Metab Engn Res Lab, Singapore, Singapore

[2] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2018年 / 26卷 / 07期

基金：

美国国家卫生研究院;

关键词：

Biocatalysis; Pharmaceuticals; Pharmaceutical intermediates; Reductases; Oxidases; Hydrolases; Lyases; Isomerases; Transaminases; DYNAMIC KINETIC RESOLUTION; ALDO-KETO REDUCTASE; ONE-POT SYNTHESIS; ASYMMETRIC-SYNTHESIS; CARBONYL REDUCTASE; CHIRAL INTERMEDIATE; EFFICIENT SYNTHESIS; DIRECTED EVOLUTION; GREEN CHEMISTRY; RATIONAL DESIGN;

D O I：

10.1016/j.bmc.2017.06.043

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Biocatalysis has been increasingly used for pharmaceutical synthesis in an effort to make manufacturing processes greener and more sustainable. Biocatalysts that possess excellent activity, specificity, ther-mostability and solvent-tolerance are highly sought after to meet the requirements of practical applications. Generating biocatalysts with these specific properties can be achieved by either discovery of novel biocatalysts or protein engineering. Meanwhile, chemoenzymatic routes have also been designed and developed for pharmaceutical synthesis on an industrial scale. This review discusses the recent discoveries, engineering, and applications of biocatalysts for the synthesis of pharmaceuticals and pharmaceutical intermediates. Key classes of biocatalysts include reductases, oxidases, hydrolases, lyases, isomerases, and transaminases. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：1275 / 1284

页数：10

共 75 条

[1] Anastas P., 1998, GREEN CHEM THEORY PR
[2] Ang EL, 2016, Biocatalysts and methods for the synthesis of armodafinil, Patent No. [US20160264945 A1, 20160264945]
[3] Enzymes for the biocatalytic production of rare sugars
Beerens, Koen
Desmet, Tom
Soetaert, Wim
[J]. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2012, 39 (06) : 823 - 834
[4] Bong Y.K., 2014, Patent, Patent No. [US8895271, 8895271, US8895271B2]
[5] Engineering the third wave of biocatalysis
Bornscheuer, U. T.
Huisman, G. W.
Kazlauskas, R. J.
Lutz, S.
Moore, J. C.
Robins, K.
[J]. NATURE, 2012, 485 (7397) : 185 - 194
[6] Improved biocatalysts by directed evolution and rational protein design
Bornscheuer, UT
Pohl, M
[J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (02) : 137 - 143
[7] Highly Efficient Production of Rare Sugars D-Psicose and L-Tagatose by Two Engineered D-Tagatose Epimerases
Bosshart, Andreas
Wagner, Nina
Lei, Lei
Panke, Sven
Bechtold, Matthias
[J]. BIOTECHNOLOGY AND BIOENGINEERING, 2016, 113 (02) : 349 - 358
[8] CARVALHO A, 2015, INT J MOL SCI, V16, P26191
[9] Exploring the chemistry and evolution of the isomerases
Cuesta, Sergio Martinez
Rahman, Syed Asad
Thornton, Janet M.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (07) : 1796 - 1801
[10] Asymmetric Synthesis of Tetracyclic Pyrroloindolines and Constrained Tryptamines by a Switchable Cascade Reaction
de Graaff, Corien
Bensch, Lisa
Boersma, Sjoerd J.
Cioc, Razvan C.
van Lint, Matthijs J.
Janssen, Elwin
Turner, Nicholas J.
Orru, Romano V. A.
Ruijter, Eelco
[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (47) : 14133 - 14136

← 1 2 3 4 5 6 7 8 →